Preclinical safety and efficacy of the recombinant CR1 drug product CSL040 in rats and cynomolgus monkeys.
Ruthsatz T, Wymann S, Velkoska E, Mansour M, Schu D, Lichtfuss M, Rossato P, FitzPatrick M, Hosback S, Dyson A, Herzog E, Martin K, Dietrich B, Hardy MP.
Ruthsatz T, et al. Among authors: fitzpatrick m.
Toxicol Appl Pharmacol. 2024 Dec 6;495:117191. doi: 10.1016/j.taap.2024.117191. Online ahead of print.
Toxicol Appl Pharmacol. 2024.
PMID: 39647511
Free article.